Volterra is building EVCare™ — the AI battery health intelligence platform for the EV fleet management market. For information on planned investment rounds, contact Volterra directly.
Investment Thesis
The EV fleet management market reaches $32B by 2030 at 22.7% CAGR. Government mandates for zero-emission public transit fleets by 2040 create non-discretionary spending at scale.
General telematics offers only surface-level battery metrics. A horizontal AI battery-intelligence category is now emerging — most visibly Electra, pursuing a public listing at a $250M+ valuation — but those platforms target OEMs, grid storage, and energy, not transit. That validates the category while leaving the transit-fleet vertical, with its agency procurement and operational workflows, open for a focused specialist. See the full comparison →
Foundation filings (CareStar™, BattHealthScore™, FitStar™), 100+ white papers, and comprehensive provisional patent opportunities identified across 18 categories represent years of foundational R&D that cannot be quickly replicated by incumbents or new entrants.
Advanced pilot discussions with leading North American transit agencies. NRC IRAP grant funding. 28+ transit agencies assessed. The demand signal is real and the problem is validated.
Ian McAvoy brings 30+ years across transportation and technology — including two decades as a transit and municipal executive operator in the UK and California, plus two prior cleantech ventures (GreenPower Motor Company and Thomson Power). This is a founder who has lived the problem from inside.
Sources: figures compiled from third-party industry and market-research estimates (EV fleet management and battery-health-monitoring market sizing, federal funding and zero-emission transit mandates). Full citations and underlying reports available in the data room on request.
Use of Proceeds
Three strategic priorities — each directly accelerating Volterra's path to recurring revenue and Series A readiness.
Convert advanced pilot discussions with leading transit agencies into commercial contracts. Onboard additional transit agency pilots across North America from the 28+ agency pipeline already developed.
Priority 1Accelerate EVCare™ v5.0 — completing the CareStar™ / BattHealthScore™ / FitStar™ three-layer architecture, hardening for enterprise deployment, and building the integrations large transit agencies require.
Priority 2Convert priority provisional patents to formal filings. Expand the team. Pursue non-dilutive grant programs (Eureka Eurostars, BC Fast Pilot) to extend runway.
Priority 3Virtual Data Room
Select documents available on request. Full access provided to qualified investors following NDA execution.
Full investor presentation covering market opportunity, product architecture, traction, team, and financial projections.
Available on request28-agency product-market fit research, competitive landscape, and go-to-market strategy for North American transit.
Available on request3-year financial projections, revenue model, unit economics, and path to Series A milestones.
NDA requiredCurrent ownership structure and capitalisation overview, provided to qualified investors under NDA.
NDA requiredFoundation filings (CareStar™, BattHealthScore™, FitStar™), 100+ white papers, comprehensive provisional patent opportunities identified across 18 categories, and independent IP valuation assessment.
NDA requiredPilot letters of intent and commercial terms with leading and pipeline transit agencies; executed agreements added as pilots are signed.
NDA requiredEVCare™ three-layer intelligence architecture, module specifications, and integration requirements documentation.
NDA requiredProposed four-entity structure, governance documents, and board composition.
Qualified investorsIntegrated Operating Plan v2.1 including staffing plan (20 positions), PMO scorecard, and 2026 commercial milestones.
Qualified investorsTraction & Validation
Advanced pilot discussions with a major North American transit agency. Battery Electric Bus fleet. Planned EVCare™ battery health monitoring and FitStar™ deployment.
In DiscussionAdvanced discussions with one of North America's largest transit authorities on EVCare™ fleet intelligence evaluation.
In DiscussionNational Research Council IRAP grant funding secured — government validation of EVCare™'s technical innovation and commercial potential.
ValidatedActive R&D collaboration with BCIT supporting EVCare™ technical development and providing access to applied research and engineering talent.
ActiveIan McAvoy speaking at Electric Fleets USA 2026 in Los Angeles — positioning Volterra on stage at the premier North American fleet electrification conference.
September 2026Comprehensive product-market fit research across 28+ North American transit agencies before writing a single line of commercial code.
CompletedA $250M+ AI battery-intelligence pure-play (Electra) is pursuing a Nasdaq listing — independent confirmation the category is real and richly valued. EVCare™ is the transit-vertical specialist within it.
TailwindGet in Touch
Volterra is not currently conducting a public securities offering through this website. For information on planned or future investment rounds, and to discuss access to investor materials under NDA, contact the company directly.
Already an EVCare™ customer? Sign in to your portal →
EVCare™ is at MVP stage today, and we’re transparent about it: the current platform delivers the core battery-health intelligence, while additional modules and capabilities will be introduced and integrated across 2027 and 2028 as we scale.